Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

Myeloid cell development and function

back to job offer list
back to clinical trials

Myeloid cell development and function : current research

This research team belongs to the UMR 1015 - Tumor immunology and immunotherapies

Remise du prix
01/28/2025

Dr. Suzette Delaloge Receives the Grand Prix de la Recherche Ruban Rose

A medical oncologist at Gustave Roussy and director of the personalised prevention program Interception, Dr. Suzette Delaloge has been honoured by the Ruban Rose Association for her research aimed at developing a saliva test capable of detecting early signs of breast cancer.

Path-For-Young, an international project to personalise care for young women with breast cancer

back to job offer list
back to clinical trials

Path-For-Young, an international project to personalise care for young women with breast cancer

Logo Path for young

Journée mondiale contre le cancer 2025 - Dossier de presse

back to job offer list
back to clinical trials

22 janvier 2025

Metro
01/20/2025

La station de métro Villejuif–Gustave Roussy est ouverte

Samedi 18 janvier, la station de métro Villejuif-Gustave Roussy située au pied de l’Institut a été inaugurée.

À la rencontre de Patricia Blanc

back to job offer list
back to clinical trials

Ils nous soutiennent
À la rencontre de Patricia Blanc
Présidente de l’association Imagine for Margo

Pour un avenir sans cancer des enfants

Livre des Cours de chimio 2024

back to job offer list
back to clinical trials
Image d'arrière plan de la frise: 
Texte du bloc: 

Le book des Cours de chimio 2024 est disponible

 

Couleur texte: 
#ffffff
Couleur D'arrière Plan: 
#ff6633
Alignement du bloc: 
à Droite
Taille du bloc: 
Normale
URL cible: 
Commander le livre

Advanced T cell therapy - Lab members

back to job offer list
back to clinical trials

Advanced T cell therapy: lab members

  • Laurie Menger PhD, HDR CRCN INSERM
  • Aurélien Sutra Del Galy MD PhD, Data scientist
  • Marguerite Laprie Sentenac, PharmD, PhD student
  • Albane Simon, PhD student
  • Chloe Slater, PhD student, collab Massachusetts General Hospital USA
  • Chuang Dong, Data scientist
  • Laetitia Perrin, Engineer
  • Janany Kandiah, Engineer

 

 

Thérapies cellulaires avancées - publications

back to job offer list
back to clinical trials

Advanced T cell therapy - Major publications

  • Ablation of FAS confers allogeneic CD3- CAR T cells with resistance to rejection by T cells and natural killer cells. Menegatti S, Lopez-Cobo S, Sutra Del Galy A, Fuentealba J, Silva L, Perrin L, Heurtebise-Chrétien S, Pottez-Jouatte V, Darbois A, Burgdorf N, Privat AL, Simon A, Laprie-Sentenac M, Saitakis M, Wick B, Webber BR, Moriarity BS, Lantz O, Amigorena S, Menger L. Nat Biomed Eng. 2024 Nov 18. doi: 10.1038/s41551-024-01282-8.

Pages